• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Safety worries spur Novartis to suspend drug dosing in Huntington’s trial

    BIOPHARMADIVE

    Sad news from Novartis: dosing suspended in VIBRANT-HD trial of branaplam

    HDBUZZ

    Novartis receives USFDA Orphan Drug Designation for branaplam (LMI070)

    PRESS RELEASE

    Novartis to pursue SMA drug branaplam in Huntington`s disease

    REUTERS

    Novartis R&D boss says doesn`t see big opportunity in oral SMA therapy

    REUTERS

    Genentech takes aim at Biogen and Novartis, highlighting an early +ve results

    ENDPTS

    Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.